API Tamoxifen Citrate / Nolvadex Powder CAS 54965-24-1 For Anti Estrogen

Short Description:

Tamoxifen Citrate is the citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients.

Contact: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

WhatsApp: +86 186 2503 6043 (WeChat & Telegram & Line)

Skype: slhyzy

Send email to us

Product Detail

Product Tags

Description

Specification

Product Name	Tamoxifen citrate
Chemical Name	(Z)-[2-[4-(1,2-diphenylbut-1-enyl)phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
Other Name	TAMOXIPHEN;Ethanamine,2-4-(1Z)-1,2-diphenyl-1-butenylphenoxy-N,N-dimethyl-,2-hydroxy-1,2,3-propanetricarboxylate(1:1);TAMOXIFENCITRATE,USP;TAMOXIFENCITRATEANTI-ESTROGENChemicalbook,PROTEI;TomixipheneCitrate;(Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-buteneCitrate;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine,citrate(1:1)
CAS Number	54965-24-1
Molecular Formula	C32H37NO8
Formula Weight	563.64
Appearance	White, fine, crystalline powder
Assay	99.0% min
Melting Point	140-144 °C
Package	bag, bottle, drum, or as you required
Storage	Store the container tightly closed in a dry & cool place. Do not expose to direct sunlight.
COA & MSDS	Available
Application	For research purpose

Certificate of Analysis/COA

Test Items	Specification	Test Results
Description	white, fine, crystalline powder	Pass
Identification	IR,UV conform	Pass
Solubility	Very slightly soluble in water,in acetone,in chloroform,and in alcohol;soluble in methanol.melt at 142°with decomposition.	Pass
Assay(on dry basis)	≥99.0%	99.23%
Loss on drying	Not more than 0.5%	0.26%
Residue on ignition	Not more than 0.2%	0.06%
iron	Not more than 0.05%	0.0016%
Residual solvents	Not more than 0.5%	Pass
Acetone	Not more than 0.5%	0.2%(G/G)
Heavy metals	Not more than 0.001%	0.0007%
E-isonet	Not more than 0.3%	0.2%
Conclusion	comforms to USP 37

Usage

Tamoxifen citrate is also approved to prevent: Breast cancer in women who are at high risk for the cancer. Tamoxifen citrate is also being studied in the treatment of other types of cancer.